What is the translation of " 次要终点包括 " in English?

• secondary endpoints included
• secondary end points included
• secondary endpoints include

Examples of using 次要终点包括 in Chinese and their translations into English

次要终点包括远处转移和局部和区域复发率。
Secondary endpoints included distant metastasis and local and regional recurrence rates.

关键次要终点包括HbA1c和体重从基线到第52周的变化。
Secondary endpoints included change in HbA1c and body weight at 52 weeks.

次要终点包括无进展生存期(PFS)和安全性。
The secondary end points included progression-free survival(PFS) and safety.

次要终点包括无进展生存期(PFS)和安全性。
Secondary endpoints included progression-free survival(PFS) and safety.

次要终点包括应答持续时间。
Other secondary endpoints include duration of response.

次要终点包括OS，应答，临床获益率和安全性。
Secondary endpoints included OS, response, clinical benefit rate, and safety.

次要终点包括功效测量。
Secondary end points include efficacy evaluation and measurements.

次要终点包括根据RECISTv1.1评估的客观缓解率（ORR）、颅内ORR、颅内PFS、总生存期（OS）、安全性和耐受性。
Secondary endpoints included objective response rate per RECIST v1.1, intracranial ORR, intracranial PFS, overall survival, safety and tolerability.

次要终点包括其他心血管疾病结局，健康相关的生活质量，打鼾症状，白天嗜睡和情绪。
Secondary end points included other cardiovascular outcomes, health-related quality of life, snoring symptoms, daytime sleepiness, and mood.

关键次要终点包括研究者评估的PFS，OS，和ITT人群以及EGFR和ALK突变亚组的安全性。
Key secondary endpoints included investigator-assessed PFS and OS, safety in the ITT population and in EGFR and ALK mutation subgroups.

次要终点包括基于DSM-5、actigraphy(客观睡眠测量)的PTSD症状清单；.
Secondary endpoints include PTSD symptom checklist based on DSM-5, actigraphy(objective sleep measure);

次要终点包括无进展生存期，反应率（最佳反应是完全或部分反应的患者比例）和安全性。
Secondary end points included progression-free survival, response rate(the proportion of patients whose best response was a complete or partial response), and safety.

次要终点包括ORR、疾病控制率、肿瘤体积缩小、患者报告的结局与安全性。
And the secondary endpoints included ORR, disease control rate, tumor shrinkage, patient-reported outcomes and safety.

关键次要终点包括总生存期、总体缓解率、研究者评估的PFS、安全性和耐受性。
Key secondary endpoints include overall survival, overall response rate, PFS by investigator, and safety and tolerability.

次要终点包括总体生存(OS)和客观反应率(ORR)。
Secondary endpoints included overall survival(OS) and objective response rate(ORR).

次要终点包括PFS，OS，反应持续时间，安全性和耐受性。
Other secondary endpoints include PFS, duration of response, safety and tolerability.

关键次要终点包括HbA1c和体重从基线到第52周的变化。
Key secondary endpoints included change in HbA1c and bodyweight from baseline to week 52.

除安全性外，关键次要终点包括持久反应和完全的血液系统缓解。
In addition to safety, key secondary endpoints include durable response and complete hematological remission.

主要研究终点为无进展生存期，关键次要终点包括至疾病二次进展或死亡的时间以及总生存期。
The primary endpoint was progression-free survival and key secondary endpoints included time to second disease progression or death and overall survival.

次要终点包括功能、疾病活动性和生活质量的其他指标。
Secondary endpoints include other measures of function, disease activity, and quality of life.

次要终点包括体征和症状、躯体功能和患者自诉的转归等其他指标。
Secondary endpoints include other measures of signs and symptoms, physical function and patient-reported outcomes.

次要终点包括总体生存率，客观反应，临床获益率，患者报告的结局和安全性。
The secondary endpoints included overall survival, objective response, rate of clinical benefit, patient-reported outcomes, and safety.

次要终点包括药代动力学，减轻流感症状和症状的时间以及症状持续时间，包括发烧。
Secondary endpoints included pharmacokinetics, time to alleviation of influenza signs and symptoms and duration of symptoms, including fever.

次要终点包括总生存期，客观反应，临床获益率，患者报告结果和安全性。
The secondary endpoints included overall survival, objective response, rate of clinical benefit, patient-reported outcomes, and safety.

除了主要终点PFS，次要终点包括OS、安全性和耐受性。
The primary endpoint was OS, and key secondary endpoints included PFS, safety and tolerability.

除了主要终点PFS，次要终点包括OS、安全性和耐受性。
In addition to the primary endpoint of PFS, secondary endpoints included OS, safety and tolerability.

次要终点包括到第二次进展或死亡的时间（PFS2）、总生存期（OS）和与健康相关的生活质量。
Secondary endpoints included time to second progression or death(PFS2), overall survival and health-related quality of life.

主要终点为OS，次要终点包括ORR、PFS、安全性、根据PD-L1表达的功效，以及患者报告结果。
The primary endpoint was OS, while the secondary endpoints included ORR, PFS, safety, efficacy according to PD-L1 expression, and patient-reported outcomes.

次要终点包括无通气辅助生存（VAFS）、呼吸能力、肌肉力量、神经纤维轻链（NfL）血清浓度和安全性。
Secondary endpoints will include ventilation assistance-free survival(VAFS), respiratory capacity, muscle strength, neurofilament light chain(NfL) serum concentrations and safety.